星光疗法:减少乳腺癌妇女的焦虑,接受首次治疗
Alexa Lahera1, Leonardo Martinez2, Jilian Manrique3
1Alexa Lahera.
Clinical journal of oncology nursing
|February 6, 2026
概括
星光疗法是一种新的感官干预,有效地减少了接受乳腺癌化疗的女性的焦虑. 这项试点研究表明其可行性和可接受性,用于管理与治疗相关的焦虑.
科学领域:
- 在瘤学瘤学.
- 心理学 心理学 心理学
- 补充疗法 补充疗法 补充疗法
背景情况:
- 焦虑是患有乳腺癌的女性普遍且经常未得到充分治疗的症状.
- 在化疗治疗期间,焦虑水平可以显著增加.
- 斯诺泽伦®多感官环境,利用像光投射这样的感官参与,以其平静的效果而闻名.
研究的目的:
- 评估星光疗法的可行性和可接受性.
- 为了确定星光疗法是否可以减少乳腺癌患者在初始化疗期间的焦虑.
- 在门诊护理环境中评估星光疗法.
主要方法:
- 一项试点研究,采用单组前/后测试设计.
- 涉及30名患有乳腺癌的女性,她们在第一天接受化疗/免疫疗法.
- 在治疗日的四个时间点收集的数据.
主要成果:
- 发现星光疗法对患者来说是可行的和可以接受的.
- 在治疗周期1,第一天的参与者中观察到焦虑水平的降低.
- 没有患者报告治疗后或输液后的临床焦虑.
结论:
- 星光疗法是一种可行的干预措施,用于在化疗期间管理乳腺癌患者的焦虑.
- 这些发现支持进一步调查星光疗法在支持性癌症护理中的作用.
- 这种感官干预有望改善患者在治疗期间的体验.
相关概念视频
02:49Cancer Therapies
10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
02:57Targeted Cancer Therapies
8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.9K
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
01:18Anxiety: Overview
1.1K
Anxiety is a common mental disorder featuring excessive worry, fear, and apprehension, significantly affecting daily life. People with anxiety disorders experience persistent and intense anxiety, interrupting their everyday functioning.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
1.1K
03:11Oxidation-Reduction Reactions
75.8K
Oxidation–Reduction Reactions
75.8K
01:30Generalized Anxiety Disorder
731
Generalized Anxiety Disorder (GAD) is a chronic condition characterized by excessive and uncontrollable worry that persists for at least six months, significantly interfering with daily functioning. Unlike situational anxiety, which arises in response to specific stressors, GAD often occurs without a clear cause. Individuals may experience disproportionate worry about work, health, or relationships. For instance, a person might continuously fear poor health despite normal medical evaluations or...
731